Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reports

  • P. van Mourik*
  • , E. C. van der Hout
  • , H. D. Luijk
  • , R. W. Hofland
  • , A. H.W. Bruns
  • , H. G.M. Heijerman
  • , I. Bronsveld
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Downloads (Pure)

Abstract

Highly effective modulator treatment (HEMT) has resulted in an improved prognosis for people with cystic fibrosis (pwCF). In this case report, we present two pwCF with clinical stabilization after start of HEMT who developed complicated fungal infections after several years of clinical stability, highlighting the importance of continued careful monitoring of pwCF on HEMT and considering early antifungal treatment in this population.

Original languageEnglish
Article number102278
JournalRespiratory Medicine Case Reports
Volume57
DOIs
Publication statusPublished - Jan 2025

Keywords

  • Cystic fibrosis
  • Elexacaftor/tezacaftor/ivacaftor
  • Scedosporium

Fingerprint

Dive into the research topics of 'Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reports'. Together they form a unique fingerprint.

Cite this